THE INDUSTRY’S LARGEST MARKETPLACE FOR PHARMACEUTICALS
domestic-supply.org has been in operation for almost 30 years, acquiring 50’s of thousands of satisfied customers.
domestic-supply.org works very hard to establish trust with our customer. Our high-quality products and professional staff is testament to the legitimacy of our business practice.
Each brand is hand-selected and goes through a very thorough review process.
Quality is held in a very high regard at domestic-supply.org. To further legitimize these products, we do have a comprehensive
Featured
Ultima-Dbol 25
ACTIVE HALF-LIFE 5-6 hours CLASSIFICATION Anabolic Steroid DOSAGE 150-350 mg/week ACNE Yes WATER RETENTION ..
Pharma MIX 4
ACTIVE HALF-LIFE 6-7 days CLASSIFICATION Anabolic Steroid DOSAGE Men: 600-1200 mg/week ACNE Yes WATER ..
Bactrim Forte 800/160
MANUFACTURER Deva WAREHOUSE International Warehouse 2 ACTIVE INGREDIENTS Sulfamethoxazole and Trimethoprim..
CJC1295 2mg
CLASSIFICATION: GHRH Analogue ACNE: No WATER RETENTION: No HBR: No HEPATOTOXICITY: No AROMATIZATION: No MANUFACTURER: Beligas WAREHOUSE: Intern..
Clenbuterox
ACTIVE HALF-LIFE 48-72 Hours CLASSIFICATION Beta-2 Agonist, Bronchodilator DOSAGE Men: 100-140 mcg/day; Women: 80-100 mcg/day ..
Muscle Definition Women Cycle
**2 x Ultima-Primo 100** - Ultima Pharmaceuticals [10 ml x 100 mg/ml] **10 x Ultima-Oxa 10** - Ultima Pharmaceuticals [50 pills x 10 mg] ..
Zhewitra-20
ACTIVE HALF-LIFE 5-7 hours CLASSIFICATION PDE5 inhibitor DOSAGE Men 10-20 mg/day ACNE No WATER ..
Ultima-Superdrol
ACTIVE HALF-LIFE 8-12 hours CLASSIFICATION Anabolic Steroid DOSAGE 10-20 mg/day ACNE Rarely WATER..
Turinabolos 25
ACTIVE HALF-LIFE 16 hours CLASSIFICATION Anabolic Steroid DOSAGE Men: 20-50 mg/day ACNE Yes WA..
Ultima-IGF-1 LR3 0.1mg
CLASSIFICATION Peptide Hormone ACNE No WATER RETENTION No HBR No HEPATOTOXICITY No AROMATIZATION No MANUFACTURER Ultima Peptides WAREHOUSE Inte..
Apto-Turinabol
ACTIVE HALF-LIFE 16 hours CLASSIFICATION Anabolic Steroid DOSAGE Men: 20-50 mg/day ACNE Yes WATER RETENTION Low HBR Po..












